Detalles de la búsqueda
1.
Pilot Evaluation of Angiogenesis Signaling Factor Response after Transcatheter Arterial Embolization for Hepatocellular Carcinoma.
Radiology
; 285(1): 311-318, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28787261
2.
Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer.
Invest New Drugs
; 32(2): 330-9, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24173967
3.
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.
Invest New Drugs
; 32(4): 700-9, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24711126
4.
Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or without bevacizumab.
Prostate Cancer Prostatic Dis
; 2024 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38347114
5.
A phase II study of capecitabine, oxaliplatin, and bevacizumab in the treatment of metastatic esophagogastric adenocarcinomas.
Oncologist
; 18(3): 271-2, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23485624
6.
Cabozantinib with or without Panitumumab for RAS wild-type metastatic colorectal cancer: impact of MET amplification on clinical outcomes and circulating biomarkers.
Cancer Chemother Pharmacol
; 89(3): 413-422, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35171350
7.
Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance).
Clin Cancer Res
; 28(13): 2771-2778, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34965953
8.
Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance).
Clin Cancer Res
; 28(13): 2779-2788, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34965954
9.
Prognostic and Predictive Biomarkers in Patients with Metastatic Colorectal Cancer Receiving Regorafenib.
Mol Cancer Ther
; 19(10): 2146-2154, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32747417
10.
Modulation of Circulating Protein Biomarkers in Cancer Patients Receiving Bevacizumab and the Anti-Endoglin Antibody, TRC105.
Mol Cancer Ther
; 17(10): 2248-2256, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29997150
11.
Biomarker signatures correlate with clinical outcome in refractory metastatic colorectal cancer patients receiving bevacizumab and everolimus.
Mol Cancer Ther
; 14(4): 1048-56, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25695956
12.
Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer.
Cancer Med
; 3(3): 580-91, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24574330
Resultados
1 -
12
de 12
1
Próxima >
>>